As of 2024-12-12, the Fair Value of InDex Pharmaceuticals Holding AB (INDEX.ST) is -0.53 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 45.30 SEK, the upside of InDex Pharmaceuticals Holding AB is -101.17%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -87.77 | -57.42 | -103.04 | -100.33 | -95.26 | -88.77 |
| YoY growth | -6.85% | 34.58% | -79.46% | 2.63% | 5.05% | -8.81% |
| Market Cap (mil) | 245.35 |
| P/E | |
| Forward P/E |
| EPS | -0.11 |
| Avg earnings growth rate | -8.81% |
| TTM earnings | -56.48 |